Risk factor
Resilient to price shocks
Profitability factor
Very low or no dividends
About
Established in 1985 and headquartered in Taizhou, China, Wanbangde Pharmaceutical Holding Group Co., Ltd. primarily focuses on the research, development, manufacturing, and distribution of traditional Chinese medicines, active pharmaceutical ingredients (APIs), and various medicinal preparations. The company also extends its operations into the medical technology field, developing products such as orthopedic implant devices, general medical equipment, protective gear, and disposable sterile polymer medical consumables. Complementary to its product offerings, it provides specialized hospital engineering services. Initially known as Wanbangde New Building Materials Co., Ltd., the company officially adopted its current name, Wanbangde Pharmaceutical Holding Group Co., Ltd., in April 2020.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is trading at neutral levels on P/FCF.